The TRUST trial in ovarian cancer: a missed opportunity or a turning point? The position of the Italian MITO group

Martina Arcieri, Sandro Pignata, Domenica Lorusso, Anna Fagotti, Vito Chiantera, Antonino Ditto, Giorgio Valabrega, Claudia Marchetti, Claudio Zamagni, Valentina Tuninetti, Alberto Farolfi, Stefano Restaino, Giuseppe Vizzielli

Open source

DOI
10.3389/fonc.2026.1853078
Published
2026-05-28
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1853078,
  title = {The TRUST trial in ovarian cancer: a missed opportunity or a turning point? The position of the Italian MITO group},
  author = {Martina Arcieri and Sandro Pignata and Domenica Lorusso and Anna Fagotti and Vito Chiantera and Antonino Ditto and Giorgio Valabrega and Claudia Marchetti and Claudio Zamagni and Valentina Tuninetti and Alberto Farolfi and Stefano Restaino and Giuseppe Vizzielli},
  year = {2026},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2026.1853078},
  url = {https://doi.org/10.3389/fonc.2026.1853078}
}

RIS

TY  - JOUR
TI  - The TRUST trial in ovarian cancer: a missed opportunity or a turning point? The position of the Italian MITO group
AU  - Martina Arcieri
AU  - Sandro Pignata
AU  - Domenica Lorusso
AU  - Anna Fagotti
AU  - Vito Chiantera
AU  - Antonino Ditto
AU  - Giorgio Valabrega
AU  - Claudia Marchetti
AU  - Claudio Zamagni
AU  - Valentina Tuninetti
AU  - Alberto Farolfi
AU  - Stefano Restaino
AU  - Giuseppe Vizzielli
PY  - 2026
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1853078
UR  - https://doi.org/10.3389/fonc.2026.1853078
ER  - 

APA

Arcieri, M., Pignata, S., Lorusso, D., Fagotti, A., Chiantera, V., Ditto, A., Valabrega, G., Marchetti, C., Zamagni, C., Tuninetti, V., Farolfi, A., Restaino, S., & Vizzielli, G. (2026). The TRUST trial in ovarian cancer: a missed opportunity or a turning point? The position of the Italian MITO group. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1853078

Source records